Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques

ISBN-13: 9783030153007 / Angielski / Twarda / 2019 / 174 str.

Joseph D. Feuerstein; Adam S. Cheifetz

Spis treści

1 Epidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases

Sanjay K. Murthy, Geoffrey C. Nguyen

2 Screening for Colon Cancer in Inflammatory Bowel Disease

Kendall Beck, Fernando Velayos 

3 Skin Cancer Risk and Screening in Patients with Inflammatory Bowel Disease

Reid L Hopkins, Jamie Abbott, Debjani Sahni, Francis A. Farraye

4 Female Specific Cancern Risks and Screening in Inflammatory Bowel Disease 

Kara De Felice, Sunanda Kane

5 Lymphoma Risk and Screening in Inflammatory Bowel Disease

Chip Alex Bowman, Garrett Lawlor

6 Pouch Neoplasia following IPAA in Patients with Underlying Inflammatory Bowel Diseases

Freeha Khan, Bo Shen

7 Other Cancers: Small Bowel Cancers, Cholangiocarcinoma, Urinary Tract, and Anal Cancer Risk and Screening in Inflammatory Bowel Disease

Fernanda Dal Bello, Alan C. Moss 

8 Cancer Risks and Screening with Current and Emerging Drug Therapies in Inflammatory Bowel Diseases 

Helen Lee, Yecheskel Schneider, Gary R. Lichtenstein

9 Preventing Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Chemopreventive and Surgical Approaches

Siddharth Singh

10 Cancer Risk and Screening in Pediatric Patients 

Matthew Kowalik, Stacy A. Kahn

11 Colorectal Cancer Risk and Screening in Geriatric Patients 

Elissa Lin, Seymour Katz

12 Use of Biologic Drugs Following an Initial Diagnosis of Malignancy  

Jordan Axelrad, Shannon Chang, David Hudesman

O autorze

Joseph D. Feuerstein, MD

Beth Israel Deaconess Medical Center

Center for Inflammatory Bowel Disease

Harvard Medical School

Boston, MA

USA

Adam S. Cheifetz, MD

Beth Israel Deaconess Medical Center

Center for Inflammatory Bowel Disease

Harvard Medical School

Boston, MA

USA

Blurb

This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging drug therapies are also discussed. 

Written by experts in the field, Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease.